Mitochondrial dysfunction is an important mechanism in the pathogenesis of neurodegenerative diseases such as Parkinson disease and amyotrophic lateral sclerosis (ALS). DJ-1 and PTEN-induced putative kinase 1 (PINK1) are important proteins for the maintenance of mitochondrial function and protection against cell death. Mutations in the genes coding for these proteins cause familial forms of Parkinson disease. Recent studies have postulated that changes in the expression of both proteins are also involved in pathologic mechanisms in ALS mouse models. Here, we studied the mRNA and protein expression of PINK1 and DJ-1 in postmortem brain and spinal cord tissue and muscle biopsy samples from ALS patients and controls and in brain, spinal cord, and gastrocnemius muscle of SOD1
INTRODUCTION
Mitochondrial dysfunction plays a crucial role in the pathogenesis of Parkinson disease (PD), a chronic neurodegenerative movement disorder. Its histopathologic hallmarks are loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (1) . Mutations in genes that are associated with mitochondria, such as DJ-1 (PARK7), PINK1 (PARK6), and PARKIN (PARK2), cause autosomalrecessive PD (2, 3) .
Several studies demonstrate that PTEN-induced putative kinase 1 (PINK1) expression is important for maintaining mitochondrial integrity. PINK1 influences mitochondrial function via modulation of electron transport chain complex activities (4) and contributes to mitochondrial homeostasis and mitophagy by PINK1-mediated recruitment of PARKIN (PARK2) to damaged mitochondria (5Y8). Neurons of PINK1-knockout mice show mitochondrial dysfunction that includes impaired respiratory chain and calcium overload (9) . Increased oxidative stress was detected in human cells carrying a PINK1 mutation (10) , and PINK1 knockout in flies results in swollen and defective mitochondria (11) . PINK1-knockout flies also have reduced electron transport chain activity, which implicates lower cellular adenosine triphosphate production (4) . Loss of PINK1 also causes phenotypic changes such as neuronal and muscular degeneration in Drosophila and gait abnormalities in mouse models (12Y15).
The DJ-1gene encodes a 189Yamino acid protein that is highly expressed in brain and spinal cord, particularly in neurons (16Y18). It is localized in both the nucleus and the cytoplasm and is associated with microtubules (19) . Downregulation of endogenous DJ-1 induced cell death in a neuronal cell line via endoplasmic reticulum stress and proteasome inhibition, whereas DJ-1 overexpression was protective (20) . Similarly, loss of DJ-1 in primary neurons led to hypersensitivity to oxidative stress that could be rescued by overexpression of wild-type DJ-1 (21) . Upregulation and mitochondrial recruitment of DJ-1 could also be induced by neurotoxins and by specific mitochondrial toxins such as 1-methyl-4-phenylpyridinium or 6-hydroxydopamine (22, 23) . These results suggest that DJ-1 plays an important role in the cellular defense reaction against oxidative stress. In PD patients, plasma levels of DJ-1 correlate with disease severity (24) .
Oxidative stress and mitochondrial dysfunction are also important pathogenic factors in amyotrophic lateral sclerosis (ALS), a fatal disorder of the motor system leading to progressive muscle atrophy and paralysis and ultimately to death because of respiratory failure (25) . Similar to PD, there are both sporadic and familial forms of ALS, the latter accounting for approximately 10% of all cases. The first ALS-associated gene mutations were discovered in 1993 in the gene coding for superoxide dismutase 1 (SOD1), an enzyme that catalyzes important oxidative reactions (26) . This led to the generation of the mutant SOD1
G93A ALS transgenic mouse model, which, despite recent advances in ALS genetics, still represents the best-characterized animal model of ALS to date.
Previous studies on DJ-1 and PINK1 expression in the SOD1 G93A mouse model showed increased mRNA and protein levels in spinal cord and brain tissue (27Y30). It has further 
MATERIALS AND METHODS

Human Tissues
Human postmortem motor cortex of 7 patients with definite ALS according to the revised El Escorial criteria (35) and 5 controls without any history of neurologic disease, as well as spinal cord tissue (cervical and lumbar region) of 7 ALS patients and 5 controls, were available at autopsies. The postmortem delay ranged from 6 to 29 hours (Table 1) .
Tissue samples from diagnostic muscle biopsies from 6 patients with a diagnosis of progressive muscular atrophy, probable or definite ALS according to the El Escorial criteria, and aged 52 to 72 years and from 8 non-ALS control patients aged 32 to 67 years were dissected and immediately snap frozen in liquid N 2 (Table 1) .
Animals
All experiments were carried out in accordance to the internationally accepted principles in the care and use of experimental animals and were approved by the local institutional Animal Care and Research Advisory Committee and permitted by the local government. Experiments are regis tered under reference number 11/0404. G93A transgenic familial ALS mice (high copy number; B6SJLTg [SOD1
G93A
]1Gur/J) (19) were obtained from Jackson Laboratory (Bar Harbor, ME). These mice overexpress the human mutant SOD1 allele containing the Gly93 à Ala (G93A) substitution. We maintained the transgenic G93A hemizygotes by mating transgenic males with B6SJLF1/J hybrid females. Transgenic offspring were genotyped by polymerase chain reaction (PCR) assay of DNA obtained from tail tissue. As a control group, nontransgenic wild-type littermate mice were used. Mice were housed under controlled conditions (12:12 light-dark cycle), with free access to food and water. Animals of the same sex were kept in groups of up to 5 animals in Makrolon type II cages (UNO, Zevenaarb, Netherlands). Numbers of mice in each group are shown in Table 2 .
Quantitative Real-Time PCR For real-time PCR, animals were killed by cervical dislocation at different time points (day 40, day 90, and end stage of disease) to remove brain, spinal cord, and gastrocnemius muscle. After removal, the tissue samples were immediately snap frozen. Mouse and human tissue was mechanically homogenized in TRIzol reagent (Invitrogen, Eugene, OR) using a Power Gen 125 device (Thermo Fisher Scientific, Waltham, MA). RNA was isolated for 3 days, as recommended by the manufacturer.
The amount of RNA was measured with a Bio Photometer plus (Eppendorf, Hamburg, Germany) before cDNA was synthesized from total RNA (4 Kg in 10 KL for spinal cord, 2 Kg in 10 KL for motor cortex, 5 Kg in 10 KL for muscle tissue) using a high-capacity cDNA kit (Invitrogen, Darmstadt, Germany) and a cDNA Thermocycler (Bio-Rad, Hercules, CA) for 2 days.
For quantification of DJ-1 and PINK1 mRNA expression levels, the TaqMan method was used with the following assays synthesized by Lifetech (Life Technologies; Applied Biosystems, Foster City, CA): DJ-1 (human Hs00697109_m1, mouse Mm00498538_m1) and PINK1 (human Hs00260868_m1, mouse Mm00550827_m1). B2M (Hs00984230_m1) was used as a reference gene for human primers, and Hrpt1 (Mm00446968_m1) was used as a reference gene for mouse primers. Polymerase chain reactions were run in a StepOnePlus instrument (Applied Biosystems) under the following amplification conditions: 95-C for 20 seconds, followed by 40 cycles of 95-C for 1 second and 60-C for 20 seconds. Gene expression levels were normalized against the reference gene in all samples, and the relative amount of each gene was calculated via the 2^-ddct method with a threshold of 0.2 and an SD less than 0.2.
Immunohistochemistry
Human brain and spinal cord sections were cut in 12-Kmthick sections, and muscle tissues were cut in 40-Km slices with a Leica CM 3050S cryostat (Leica Biosystems, Nussloch, Germany). Postfixation was achieved by incubation of slides in 4% paraformaldehyde (PFA). For immunohisto chemical staining, slides were immersed in PBS with 1 mmol/L Tris-HCl, blocked with peroxidase block (DAKO-Cytomation, Glostrup, Denmark) for 10 minutes and 5% goat serum in PBS with 0.3% Triton X-100 (Sigma-Aldrich) for 1 hour, followed by overnight incubation at 4-C with primary antibody specific for DJ-1 (1:200, rabbit, polyclonal antibody; Millipore, Billerica, MA) diluted in 5% goat serum in PBS with 0.3% Triton X-100. Secondary horseradish peroxidaseYconjugated anti-rabbit antibody (DAKO-Cytomation) was added for 30 minutes, followed by 20-minute incubation in chromogen substrate (DAKOCytomation). Slides were covered with Dako Faramount (DAKOCytomation).
For immunofluorescence, slides were treated as previously described and incubated overnight with a primary anti body specific for PINK1 (1:50, rabbit, polyclonal antibody; Merck, Darmstadt, Germany) and PINK1 (1:200, rabbit, polyclonal antibody; Millipore). Secondary antibody Alexa Fluor 555 rabbit (Invitrogen) was added for 45 minutes. 4 ¶,6-Diamidino-2-phenylindole (Invitrogen) was used for counterstaining of nuclei. Slides were covered with Mowiol (Calbiochem, Millipore). For assessment of morphologic changes, adjacent human muscle sections were stained by PINK1 and DJ-1 immunofluorescence as described before and by hematoxylin and eosin staining.
Motor neurons were identified according to their localization in the ventral horn and their size as previously defined by Yuan et al (36) . The mean area of motoneurons in men is described as 972. 38 
Mouse Tissue
Animals were killed by cervical dislocation at different time points (Day 40, Day 90, and disease end stage). After transcardial perfusion with 25 mL 4% PFA in PBS, the lumbar part of the spinal cord was removed. Postfixation for 1 day in 4% PFA was followed by storage in 70% ethanol until dehydration by progressively more concentrated ethanol baths and xylene and embedding in paraffin blocks. Sevenmicrometer-thick sections were cut with a Leica RM 2245 microtome (Leica Biosystems), and 5 to 6 sections were transferred to 1 object slide, respectively. For immunohistochemical staining, slides were rehydrated in xylene, graded ethanol, and PBS; heated in citrate buffer for 10 minutes; and then treated as previously described for immunofluorescence staining.
For double staining with 3-nitrotyrosine and DJ-1 or PINK1, tissue was rehydrated and heated in citrate buffer for 10 minutes. As blocking solution, 2% goat serum and 1% bovine serum albumin in PBS was used for 30 minutes. The sections were incubated overnight at 4-C with the primary antibody specific for 3-nitrotyrosine (1:100, rabbit, polyclonal antibody; Millipore). As secondary antibody, Alexa Fluor 555 rabbit (Invitrogen) was added for 1 hour. An additional blocking step for 30 minutes was done before incubation with the primary antibody specific for DJ-1 or PINK1 diluted in 1% bovine serum albumin in PBS overnight at 4-C. Alexa Fluor 488 rabbit (Invitrogen) was used as secondary antibody with an incubation time of 1 hour. 4 ¶,6-Diamidino-2-phenylindole was used for nuclear counterstaining. Slides were covered with Mowiol, and pictures were taken at 20Â and 40Â magnification using an Olympus BX61 microscope.
Statistics
GraphPad Prism 5 (GraphPad Software, Inc., San Diego, CA) was used for statistical analysis. All data are shown as mean T SEM, and significance level was set as p G 0.05. Results were tested for normal distribution and analyzed by unpaired t test.
The same software was used to create scatter plots of PINK1 and DJ-1 expression in correlation to disease duration or the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (37) 
RESULTS
Real-Time PCR
DJ-1 mRNA levels were not altered at the preclinical time point in muscle tissue of SOD1 G93A mice but were significantly decreased at later stages (p G 0.001 at Day 90 and p G 0.05 at end stage) versus controls (Fig. 1A) . Messenger RNA levels in human ALS muscle were also less versus controls, but the significance level was not reached (Fig. 1A) .
We did not detect significant changes in DJ-1 mRNA expression in spinal cord or in brain tissue in SOD1
G93A as compared with that in nontransgenic mice (Fig. 1C, E) . In human spinal cord and brain tissue of ALS patients, there was only a slight increase of DJ-1 mRNA levels compared with those in control tissue (Fig. 1C, E) .
The relative amount of PINK1 mRNA in muscles of SOD1 G93A mice was significantly decreased compared with controls at Day 90 and at disease end stage (p G 0.001) (Fig. 1B) . Correspondingly, there was a significant decrease in PINK1 mRNA expression in muscle biopsy samples of ALS patients versus control tissue (p G 0.05).
In spinal cord tissue of SOD1 G93A mice, PINK1 mRNA levels were significantly increased only at disease end stage (p G 0.001; Fig. 1D ), and no changes in brain tissue were detected (Fig. 1F) . In human brain and spinal cord tissue, no differences in PINK1 mRNA expression between controls and ALS patients were found (Fig. 1D, F Immunohistochemistry DJ-1 immunostaining was stronger in human motor cortex sections of ALS patients compared with that in control tissue ( Fig. 2A, B) . DJ-1 staining in human spinal cord sections of ALS patients was slightly more prominent than in controls (Fig. 2C, D) . No differences in PINK1 protein expression between ALS and control tissues were found in human motor cortex (Fig. 3A, B) or spinal cord (Fig. 3C,D) . In human muscle biopsy specimens, there was reduced DJ-1 signal intensity in ALS tissue (Fig. 4A, D) ; no clear difference could be observed for PINK1 between patient and control samples (Fig. 4B, E) . Hematoxylin and eosin staining of adjacent sections showed only mild muscle atrophy of ALS muscle because these diagnostic biopsies were obtained in a relatively early disease stage, that is, in not yet severely affected patients (Fig. 4C, F) . Immunohistochemical staining of DJ-1 in mouse spinal cord tissue resulted in stronger signals in motoneurons of SOD1
G93A compared with that in nontransgenic mice (Fig. 5A, B) . Similar results were found for PINK1, that is, spinal motoneurons of SOD1 G93A mice exhibited a more intense signal than those of nontransgenic mice (Fig. 5D, E) . Double immunofluorescence revealed colocalization of both proteins with the oxidative stress marker 3-nitrotyrosine in spinal motor neurons (Fig. 5C, F) .
DISCUSSION
Our study provides first evidence of involvement of DJ-1 and PINK1 in muscle degeneration in both SOD1 G93A mice and sporadic ALS patients. We showed a substantial reduction of DJ-1 and PINK1 mRNA expression in SOD1 G93A mice and a significant PINK1 mRNA decrease in the tissues of ALS patients. However, the results of our brain and spinal cord analyses only partially reproduce previous studies. Although these studies have described increases in DJ-1 and PINK1 in brain and spinal cord tissues of SOD1 G93A mice (28, 30) , mRNA expression levels of DJ-1 and PINK1 in brain and spinal cord of preclinical and early clinical SOD1 G93A ALS mice were not different from those in nontransgenic animals in our study. PINK1 mRNA expression was significantly increased compared with that in controls only at the disease end stage, and there was a trend toward increased DJ-1 mRNA expression in tissues of SOD1 G93A mice, corresponding to a slight increase of DJ-1 in human ALS motor cortex. In comparison with previous studies, it is noticeable that different time points were chosen. Although others used Days 120 to 125 or Week 19 (È128 days) as the end-stage time point, we defined disease end stage with a scoring system as previously described (38) . In particular, animals were killed when they showed fully developed paralysis of the hindlimbs and predominantly lay on the side and/or were not able to straighten up after turning them on the back or when they lost more than 20% of their starting weight. Pathologic events on the verge of death may narrow alterations in DJ-1 and PINK1 expression, thus explaining the lack of significant differences in these proteins at end stage as defined in our study. Whereas Lev et al (30) detected a significant increase of DJ-1 mRNA expression already at Days 85 to 95, Morimoto et al (28) did not find any differences at Week 12 (ÈDay 80), which is in line with our findings. Moreover, in both studies, groups of 4 sex nonmatched mice were compared. Considering the high variability in this mouse model, a group size of 5 animals per group should be used as a minimum, and groups should always be sex matched (39) . We used up to 9 animals per group and ensured sex matching, thereby reducing the risk of strain-dependent variations. In the study by Lev et al (30) , CNS-derived mRNA, sometimes without further specification, was measured, leaving the question as to whether brain or spinal cord tissue was used. These methodological differences compromise the comparison of our results with the previous studies.
By immunohistochemistry, however, we observed uniformly greater neuronal staining for both proteins in brain and spinal cord tissues of SOD1 G93A mice versus controls and also for DJ-1 in motor cortex and spinal cord of sporadic ALS patients.
Increased expression of PINK1 has also been found in glial cytoplasmic inclusions of patients with multiple system atrophy, as well as in Lewy bodies in PD patients (40) . CanetAviles et al (22) found that DJ-1 is translocated from cytoplasm and nucleus to mitochondria after the addition of H 2 O 2 as inducer of oxidative stress. This may indicate that recruitment and redistribution of PINK1 are induced by a dramatic increase in oxidative stress in brain and spinal cord tissue areas that are affected by neurodegenerative processes, particularly in terminal disease stages, perhaps as a compensation mechanism, as previously suggested by Morimoto et al (28) . This is supported by our observation of direct colocalization of DJ-1 and PINK1 with the oxidative stress marker 3-nitrotyrosine in spinal motor neurons. DJ-1 and PINK1 both are involved in the protection of cells against oxidative stress, whereby both proteins together seem to act in a common pathway for prevention of neuronal cell death (41) . Both wild-type and mutant DJ-1Y and PINK1Yexpressing cells are able to form complexes physically (41) . DJ-1 even forms complexes with SOD1, leading to reduced cell toxicity by antioxidative effects (31) . A study in Caenorhabditis elegans showed that loss of PINK1 increased oxidative stress sensitivity that was linked to mitochondrial dysfunction and defects in neurite outgrowth (42) .
Indeed, mitochondrial stress is one of several important factors contributing to ALS. Muscle tissue contains a high amount of mitochondria, and a so-called dying-back mechanism starting in the mitochondria of muscles might be involved in the pathogenesis of early ALS (43) . Respiratory chain deficits and abnormalities in mitochondrial DNA in muscle biopsy samples of sporadic ALS patients have already been reported (44) , and an important role of DJ-1 for maintenance of muscle function has been described (22) .
Recent experiments from our laboratory support the suggestion that mitochondria could be primary targets for mutant SOD1-mediated damage but also in sporadic ALS, and that decreased expression of several transcription factors involved in mitochondrial function, such as PGC-1>, Tfam, and NRF-1 in muscle tissue, contribute to metabolic abnormalities (45) . This is in line with the results of the present study, that is, we found significantly decreased mRNA levels of PINK1 and DJ-1 in muscle tissue already at early-onset as well as end-stage SOD1 G93A mice. We also detected a significant reduction of PINK1 mRNA expression in muscle tissues of ALS patients, a nonsignificant decrease in DJ-1 mRNA, and a decreased DJ-1 protein expression by muscle immunohistochemistry.
In view of the fact that the muscle tissue, as opposed to postmortem brain and spinal cord specimens, is mainly obtained for diagnostic purposes and therefore collected from patients at earlier disease stages, one would expect an even stronger difference between control and ALS tissue at the end stage of the disease or after death, respectively. This remains to be further analyzed, ideally, by postmortem analysis of muscle tissue from the same patients whose biopsy material we used here or at least in other postmortem ALS muscle specimens. Downregulation of both proteins in diagnostic muscle biopsy samples implies that they contribute to mitochondrial dysfunction and impairment of muscle metabolism early in the disease course.
In summary, we provide evidence of involvement of PINK1 and DJ-1 in mitochondrial dysfunction and muscle degeneration both in ALS patients and the SOD1 G93A ALS mouse model. These results warrant further investigation for the development of therapeutic approaches aimed at increasing the expression of both proteins.
